303 related articles for article (PubMed ID: 36880911)
21. Association of Medicaid Expansion in Arkansas With Postpartum Coverage, Outpatient Care, and Racial Disparities.
Steenland MW; Wilson IB; Matteson KA; Trivedi AN
JAMA Health Forum; 2021 Dec; 2(12):e214167. PubMed ID: 35977301
[TBL] [Abstract][Full Text] [Related]
22. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use.
Hollander MAG; Chang CH; Douaihy AB; Hulsey E; Donohue JM
Drug Alcohol Depend; 2021 Oct; 227():108927. PubMed ID: 34358766
[TBL] [Abstract][Full Text] [Related]
23. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
[TBL] [Abstract][Full Text] [Related]
24. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
[TBL] [Abstract][Full Text] [Related]
25. Race, ethnicity, and emergency department post-overdose care.
Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
[TBL] [Abstract][Full Text] [Related]
26. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare.
Gibbons JB; McCullough JS; Zivin K; Brown ZY; Norton EC
J Subst Use Addict Treat; 2024 Feb; 157():209271. PubMed ID: 38135120
[TBL] [Abstract][Full Text] [Related]
27. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
Johnson NL; Choi S; Herrera CN
J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
Lee S; Sun L; Vakkalanka JP
Am J Emerg Med; 2024 May; 82():52-56. PubMed ID: 38795424
[TBL] [Abstract][Full Text] [Related]
29. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.
Schiff DM; Nielsen TC; Hoeppner BB; Terplan M; Hadland SE; Bernson D; Greenfield SF; Bernstein J; Bharel M; Reddy J; Taveras EM; Kelly JF; Wilens TE
Am J Obstet Gynecol; 2021 Oct; 225(4):424.e1-424.e12. PubMed ID: 33845029
[TBL] [Abstract][Full Text] [Related]
30. Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care.
Faiz J; Bernstein E; Dugas JN; Schechter-Perkins EM; Nentwich L; Nelson KP; Cleveland Manchanda EC; Young L; Pare JR
Am J Emerg Med; 2022 Apr; 54():221-227. PubMed ID: 35180668
[TBL] [Abstract][Full Text] [Related]
31. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?
Medicaid Outcomes Distributed Research Network
J Subst Abuse Treat; 2022 Nov; 142():108807. PubMed ID: 35649885
[TBL] [Abstract][Full Text] [Related]
32. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.
Busch AB; Greenfield SF; Reif S; Normand ST; Huskamp HA
J Subst Abuse Treat; 2020 Aug; 115():108040. PubMed ID: 32600627
[TBL] [Abstract][Full Text] [Related]
33. Patient Sociodemographics and Comorbidities and Birth Hospital Characteristics Associated With Postpartum Emergency Department Care.
Zarrin H; Vargas-Torres C; Janevic T; Stern T; Lin MP
JAMA Netw Open; 2023 Mar; 6(3):e233927. PubMed ID: 36943266
[TBL] [Abstract][Full Text] [Related]
34. Postpartum medication for opioid use disorder outcomes associated with prenatal treatment and neighborhood-level social determinants.
Martin CE; Britton E; Shadowen H; Johnson J; Sabo R; Cunningham P
Am J Obstet Gynecol MFM; 2023 Nov; 5(11):101173. PubMed ID: 37783277
[TBL] [Abstract][Full Text] [Related]
35. Prenatal opioid use as a predictor of postpartum suicide attempts among reproductive-age women enrolled in Oregon Medicaid.
Yoon J; Masoumirad M; Bui LN; Richard P; Harvey SM
BMC Womens Health; 2024 Mar; 24(1):196. PubMed ID: 38528563
[TBL] [Abstract][Full Text] [Related]
36. Disparities by Sex in COVID-19 Risk and Related Harms Among People with Opioid Use Disorder.
Martin CE; Thakkar B; Taylor DDH; Chapman DA
J Womens Health (Larchmt); 2022 May; 31(5):640-647. PubMed ID: 35171036
[No Abstract] [Full Text] [Related]
37. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
[TBL] [Abstract][Full Text] [Related]
38. The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia.
Saloner B; Landis R; Stein BD; Barry CL
Health Aff (Millwood); 2019 Apr; 38(4):633-642. PubMed ID: 30933592
[TBL] [Abstract][Full Text] [Related]
39. Racial and Ethnic Disparities in Postpartum Care in the Greater Boston Area During the COVID-19 Pandemic.
Mi T; Hung P; Li X; McGregor A; He J; Zhou J
JAMA Netw Open; 2022 Jun; 5(6):e2216355. PubMed ID: 35737390
[TBL] [Abstract][Full Text] [Related]
40. Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort.
Wang X; Meisel Z; Kellom K; Whitaker J; Strane D; Chatterjee A; Rosenquist R; Matone M
Drug Alcohol Depend Rep; 2023 Dec; 9():100206. PubMed ID: 38045493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
